ImmunoGen, Inc. (Nasdaq: IMGN) and Novartis (NYSE: NVS) entered into a collaboration agreement for targeted anticancer therapeutics.

Novartis will ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE